Fieldpoint Private Securities LLC purchased a new stake in UnitedHealth Group Inc (NYSE:UNH) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 8,013 shares of the healthcare conglomerate’s stock, valued at approximately $1,569,000.
A number of other institutional investors and hedge funds have also bought and sold shares of UNH. Beach Investment Management LLC. bought a new position in UnitedHealth Group during the 2nd quarter worth $556,000. Rhumbline Advisers increased its position in UnitedHealth Group by 1.8% during the 2nd quarter. Rhumbline Advisers now owns 1,680,937 shares of the healthcare conglomerate’s stock worth $311,679,000 after buying an additional 30,105 shares during the period. Sigma Planning Corp increased its position in UnitedHealth Group by 5.0% during the 2nd quarter. Sigma Planning Corp now owns 17,068 shares of the healthcare conglomerate’s stock worth $3,165,000 after buying an additional 811 shares during the period. IFC Holdings Incorporated FL increased its position in UnitedHealth Group by 1.2% during the 2nd quarter. IFC Holdings Incorporated FL now owns 30,911 shares of the healthcare conglomerate’s stock worth $5,732,000 after buying an additional 357 shares during the period. Finally, Wedbush Securities Inc. increased its position in UnitedHealth Group by 0.9% during the 2nd quarter. Wedbush Securities Inc. now owns 16,112 shares of the healthcare conglomerate’s stock worth $2,987,000 after buying an additional 141 shares during the period. Institutional investors and hedge funds own 86.24% of the company’s stock.
UNH has been the topic of several recent research reports. Jefferies Group increased their price objective on UnitedHealth Group from $215.00 to $225.00 and gave the stock a “buy” rating in a research report on Friday, October 13th. BMO Capital Markets initiated coverage on UnitedHealth Group in a research report on Monday, October 16th. They set an “outperform” rating and a $250.00 price objective on the stock. Cantor Fitzgerald reiterated a “buy” rating and set a $208.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, October 17th. Piper Jaffray Companies increased their price objective on UnitedHealth Group to $228.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 17th. Finally, Leerink Swann reiterated a “buy” rating and set a $240.00 price objective (up previously from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Two equities research analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company. The company has an average rating of “Buy” and an average price target of $243.22.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the Zacks’ consensus estimate of $2.50 by $0.09. The company had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. UnitedHealth Group’s revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the business earned $2.11 earnings per share. analysts expect that UnitedHealth Group Inc will post 12.51 EPS for the current fiscal year.
In related news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the sale, the director now directly owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $221.75, for a total value of $5,011,106.50. Following the completion of the sale, the chief executive officer now directly owns 195,314 shares in the company, valued at $43,310,879.50. The disclosure for this sale can be found here. Insiders sold 53,853 shares of company stock worth $12,358,508 over the last ninety days. 0.89% of the stock is currently owned by insiders.
WARNING: “8,013 Shares in UnitedHealth Group Inc (UNH) Purchased by Fieldpoint Private Securities LLC” was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this report on another site, it was illegally stolen and reposted in violation of United States and international copyright and trademark legislation. The legal version of this report can be viewed at https://sportsperspectives.com/2018/02/10/8013-shares-in-unitedhealth-group-inc-unh-purchased-by-fieldpoint-private-securities-llc.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.